Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92525613 | 9252561 | 3 | F | 20120806 | 20160729 | 20130424 | 20160802 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-16860058 | BRISTOL MYERS SQUIBB | 12.96 | YR | F | Y | 0.00000 | 20160802 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92525613 | 9252561 | 1 | SS | DASATINIB | DASATINIB | 1 | Oral | INT 12AUG12 30-30NOV12-41.7MG | Y | 0 | 100 | MG | FILM-COATED TABLET | QD | |||||
| 92525613 | 9252561 | 2 | SS | DASATINIB | DASATINIB | 1 | Oral | 70 MG, UNK | Y | 0 | 70 | MG | FILM-COATED TABLET | ||||||
| 92525613 | 9252561 | 3 | PS | ETOPOSIDE. | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | INT 24DEC12 | Y | 18768 | 278 | MG | SOLUTION FOR INJECTION/INFUSION | ||||||
| 92525613 | 9252561 | 4 | SS | EXTERNAL-DOXORUBICIN HYDROCHLORIDE | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 40 MG, UNK | U | 0 | 40 | MG | |||||||
| 92525613 | 9252561 | 5 | SS | EXTERNAL-CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 1400 MG, UNK | U | 0 | 1400 | MG | |||||||
| 92525613 | 9252561 | 6 | SS | EXTERNAL-CYTARABINE | CYTARABINE | 1 | Intravenous (not otherwise specified) | 2-5OCT12-98MG 19-21DEC12-4G/M2 19-21DEC12-556MG | Y | 0 | 98 | MG | |||||||
| 92525613 | 9252561 | 7 | SS | VINCRISTINE | VINCRISTINE | 1 | Intravenous (not otherwise specified) | 1DF:2MG/2ML. EVERY 7DAYS. | U | 0 | 1 | DF | |||||||
| 92525613 | 9252561 | 8 | SS | EXTERNAL-DAUNORUBICIN | DAUNORUBICIN | 1 | Intravenous (not otherwise specified) | 23JUL12-06AUG12 ,1DF:40MG/8ML. EVERY 7DAYS DURATION 3 DOSES. 417MG IV:30NV12-30NV12 | U | 0 | 1 | DF | |||||||
| 92525613 | 9252561 | 9 | SS | PEGASPARGASE | PEGASPARGASE | 1 | Intravenous (not otherwise specified) | 1DF=3475 UNITS | U | 0 | 1 | DF | |||||||
| 92525613 | 9252561 | 10 | SS | EXTERNAL-DEXAMETHASONE | DEXAMETHASONE | 1 | Oral | 28 MG, UNK | Y | 0 | 28 | MG | |||||||
| 92525613 | 9252561 | 11 | C | NALOXONE | NALOXONE | 1 | Intravenous (not otherwise specified) | 0.05ML, 0.14ML. | U | 0 | .055 | UG | |||||||
| 92525613 | 9252561 | 12 | C | POLYETHYLENE GLYCOL 3350. | POLYETHYLENE GLYCOL 3350 | 1 | Oral | 1DF=17GM/1PACKET. | U | 0 | 1 | DF | QD | ||||||
| 92525613 | 9252561 | 13 | C | SIMETHICONE (DIMETHICONE) | DIMETHICONE | 1 | Oral | TABS: EVERY 6HRS. | U | 0 | 80 | MG | |||||||
| 92525613 | 9252561 | 14 | C | DEXTROSE. | DEXTROSE | 1 | Intravenous (not otherwise specified) | 5 %, UNK | U | 0 | 5 | PCT | |||||||
| 92525613 | 9252561 | 15 | C | HYDROMORPHONE | HYDROMORPHONE | 1 | Unknown | 15 MG, UNK | U | 0 | 15 | MG | |||||||
| 92525613 | 9252561 | 16 | C | SODIUM CHLORIDE. | SODIUM CHLORIDE | 1 | Intravenous (not otherwise specified) | 1000 ML, UNK | U | 0 | 1000 | ML | |||||||
| 92525613 | 9252561 | 17 | C | LIDOCAINE. | LIDOCAINE | 1 | Intradermal | .5 ML, PRN | U | 0 | .5 | ML | |||||||
| 92525613 | 9252561 | 18 | C | ATIVAN | LORAZEPAM | 1 | Intravenous (not otherwise specified) | 1DF:1MG/0.5ML; 0.7MG/0.38ML; 1MG/0.5ML. 04AUG2012, 20AUG2012 | U | 0 | 1 | DF | |||||||
| 92525613 | 9252561 | 19 | C | MORPHINE | MORPHINE | 1 | Intravenous (not otherwise specified) | 1DF:2MG/1ML; 2MG/1ML. | U | 0 | 1 | DF | |||||||
| 92525613 | 9252561 | 20 | C | DIPHENHYDRAMINE. | DIPHENHYDRAMINE | 1 | Oral | 1 CAPS; EVERY 6 HRS. IV 50MG/1ML.15JUL2012. | U | 0 | 50 | MG | |||||||
| 92525613 | 9252561 | 21 | C | COLACE | DOCUSATE SODIUM | 1 | Oral | 1CAPS. | U | 0 | 50 | MG | BID | ||||||
| 92525613 | 9252561 | 22 | C | ADRENALIN | EPINEPHRINE | 1 | Intramuscular | 0.3MG/0.3ML. | U | 0 | 1 | DF | |||||||
| 92525613 | 9252561 | 23 | C | HEPARIN FLUSH | HEPARIN SODIUM | 1 | Intravenous (not otherwise specified) | 1DF:30UNITS/3ML. | U | 0 | 1 | DF | |||||||
| 92525613 | 9252561 | 24 | C | HYDROCORTISONE. | HYDROCORTISONE | 1 | Intravenous (not otherwise specified) | 100MG/2ML. | U | 0 | 1 | DF | |||||||
| 92525613 | 9252561 | 25 | C | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Intravenous (not otherwise specified) | 1DF:125MG/156.25ML. | U | 0 | 1 | DF | BID | ||||||
| 92525613 | 9252561 | 26 | C | SEPTRA | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 1TAB. | U | 0 | |||||||||
| 92525613 | 9252561 | 27 | C | VANCOMYCIN | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | 1DF:500MG/10ML. EVERY 6 HR. | U | 0 | 1 | DF | |||||||
| 92525613 | 9252561 | 28 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Intravenous (not otherwise specified) | 1DF:650MG/65ML.; 500MG/50ML. ORAL(500MG/1TAB EVERY 4 HRS PRN). | U | 0 | 1 | DF | SOLUTION FOR INFUSION | ||||||
| 92525613 | 9252561 | 29 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Intravenous (not otherwise specified) | 1DF:20MG/2ML.EVRY 12 HRS.40MG/4ML 2TIMES/DAY. 04AUG12. 40MG/4ML ONCE DAILY. 04AUG12-04AUG12. | U | 0 | 1 | DF | |||||||
| 92525613 | 9252561 | 30 | C | MAGNESIUM | MAGNESIUM | 1 | Oral | 1TAB. | U | 0 | TID | ||||||||
| 92525613 | 9252561 | 31 | C | MELATONIN | MELATONIN | 1 | Oral | 5TAB AT BED TIME. | U | 0 | 5 | MG | QD | ||||||
| 92525613 | 9252561 | 32 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Intravenous (not otherwise specified) | 37MG/0.59ML. | U | 0 | 1 | DF | BID | ||||||
| 92525613 | 9252561 | 33 | C | METRONIDAZOLE. | METRONIDAZOLE | 1 | Oral | 1TAB. | U | 0 | 500 | MG | QID | ||||||
| 92525613 | 9252561 | 34 | C | ALBUMIN | ALBUMIN HUMAN | 1 | Intravenous (not otherwise specified) | 1DF:25GM/100ML. | U | 0 | 1 | DF | |||||||
| 92525613 | 9252561 | 35 | C | CALCIUM CARBONATE. | CALCIUM CARBONATE | 1 | Oral | 1TABS. | U | 0 | 500 | MG | TID | ||||||
| 92525613 | 9252561 | 36 | C | CEFTAZIDIME. | CEFTAZIDIME | 1 | Intravenous (not otherwise specified) | 1DF:200MG/20ML, EVERY 12 HRS. | U | 0 | 1 | DF | |||||||
| 92525613 | 9252561 | 37 | C | CHLORHEXIDINE | CHLORHEXIDINE | 1 | Unknown | U | 0 | ||||||||||
| 92525613 | 9252561 | 38 | C | PERIDEX | CHLORHEXIDINE GLUCONATE | 1 | Unknown | 5 ML, QID | U | 0 | 5 | ML | QID | ||||||
| 92525613 | 9252561 | 39 | C | HALDOL | HALOPERIDOL | 1 | Unknown | UNK | U | 0 | |||||||||
| 92525613 | 9252561 | 40 | C | RISPERDAL | RISPERIDONE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 92525613 | 9252561 | 1 | Acute lymphocytic leukaemia |
| 92525613 | 9252561 | 3 | Acute lymphocytic leukaemia |
| 92525613 | 9252561 | 4 | Acute lymphocytic leukaemia |
| 92525613 | 9252561 | 5 | Acute lymphocytic leukaemia |
| 92525613 | 9252561 | 6 | Acute lymphocytic leukaemia |
| 92525613 | 9252561 | 7 | Product used for unknown indication |
| 92525613 | 9252561 | 8 | Acute lymphocytic leukaemia |
| 92525613 | 9252561 | 9 | Acute lymphocytic leukaemia |
| 92525613 | 9252561 | 10 | Acute lymphocytic leukaemia |
| 92525613 | 9252561 | 11 | Product used for unknown indication |
| 92525613 | 9252561 | 12 | Product used for unknown indication |
| 92525613 | 9252561 | 13 | Product used for unknown indication |
| 92525613 | 9252561 | 14 | Product used for unknown indication |
| 92525613 | 9252561 | 15 | Product used for unknown indication |
| 92525613 | 9252561 | 16 | Product used for unknown indication |
| 92525613 | 9252561 | 17 | Product used for unknown indication |
| 92525613 | 9252561 | 18 | Product used for unknown indication |
| 92525613 | 9252561 | 19 | Product used for unknown indication |
| 92525613 | 9252561 | 20 | Product used for unknown indication |
| 92525613 | 9252561 | 21 | Product used for unknown indication |
| 92525613 | 9252561 | 22 | Product used for unknown indication |
| 92525613 | 9252561 | 23 | Product used for unknown indication |
| 92525613 | 9252561 | 24 | Product used for unknown indication |
| 92525613 | 9252561 | 25 | Product used for unknown indication |
| 92525613 | 9252561 | 26 | Product used for unknown indication |
| 92525613 | 9252561 | 27 | Product used for unknown indication |
| 92525613 | 9252561 | 28 | Product used for unknown indication |
| 92525613 | 9252561 | 29 | Product used for unknown indication |
| 92525613 | 9252561 | 30 | Product used for unknown indication |
| 92525613 | 9252561 | 31 | Product used for unknown indication |
| 92525613 | 9252561 | 32 | Product used for unknown indication |
| 92525613 | 9252561 | 33 | Product used for unknown indication |
| 92525613 | 9252561 | 34 | Product used for unknown indication |
| 92525613 | 9252561 | 35 | Product used for unknown indication |
| 92525613 | 9252561 | 36 | Product used for unknown indication |
| 92525613 | 9252561 | 37 | Product used for unknown indication |
| 92525613 | 9252561 | 38 | Product used for unknown indication |
| 92525613 | 9252561 | 39 | Product used for unknown indication |
| 92525613 | 9252561 | 40 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 92525613 | 9252561 | HO |
| 92525613 | 9252561 | DE |
| 92525613 | 9252561 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 92525613 | 9252561 | Bacteraemia | |
| 92525613 | 9252561 | Cardiac arrest | |
| 92525613 | 9252561 | Colitis | |
| 92525613 | 9252561 | Encephalopathy | |
| 92525613 | 9252561 | Fungal sepsis | |
| 92525613 | 9252561 | Generalised oedema | |
| 92525613 | 9252561 | Large intestinal ulcer | |
| 92525613 | 9252561 | Left ventricular dysfunction | |
| 92525613 | 9252561 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 92525613 | 9252561 | 1 | 20120730 | 0 | ||
| 92525613 | 9252561 | 2 | 20121126 | 20121231 | 0 | |
| 92525613 | 9252561 | 3 | 20121222 | 0 | ||
| 92525613 | 9252561 | 4 | 20120730 | 20120806 | 0 | |
| 92525613 | 9252561 | 5 | 20121005 | 0 | ||
| 92525613 | 9252561 | 6 | 20121002 | 20121221 | 0 | |
| 92525613 | 9252561 | 7 | 20120723 | 20120806 | 0 | |
| 92525613 | 9252561 | 8 | 20120723 | 0 | ||
| 92525613 | 9252561 | 9 | 20121224 | 20121224 | 0 | |
| 92525613 | 9252561 | 10 | 20121127 | 20121224 | 0 | |
| 92525613 | 9252561 | 12 | 20120727 | 0 | ||
| 92525613 | 9252561 | 13 | 20120725 | 0 | ||
| 92525613 | 9252561 | 16 | 20120717 | 0 | ||
| 92525613 | 9252561 | 17 | 20120715 | 0 | ||
| 92525613 | 9252561 | 18 | 20120718 | 0 | ||
| 92525613 | 9252561 | 19 | 20120716 | 0 | ||
| 92525613 | 9252561 | 21 | 20120727 | 0 | ||
| 92525613 | 9252561 | 22 | 20120715 | 0 | ||
| 92525613 | 9252561 | 24 | 20120719 | 0 | ||
| 92525613 | 9252561 | 26 | 20120715 | 0 | ||
| 92525613 | 9252561 | 27 | 20120726 | 0 | ||
| 92525613 | 9252561 | 29 | 20120806 | 0 | ||
| 92525613 | 9252561 | 30 | 20120728 | 0 | ||
| 92525613 | 9252561 | 32 | 20120801 | 20120812 | 0 | |
| 92525613 | 9252561 | 33 | 20120727 | 0 | ||
| 92525613 | 9252561 | 34 | 20120805 | 20120805 | 0 | |
| 92525613 | 9252561 | 35 | 20120728 | 0 | ||
| 92525613 | 9252561 | 38 | 20120802 | 0 | ||
| 92525613 | 9252561 | 39 | 20120817 | 20120818 | 0 | |
| 92525613 | 9252561 | 40 | 20120821 | 20120827 | 0 |